EBS EMERGENT BIOSOLUTIONS INC

Ownership history in Values First Advisors, Inc.  ·  16 quarters on record

This page tracks every 13F SEC filing in which Values First Advisors, Inc. reported a position in EMERGENT BIOSOLUTIONS INC (EBS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.07% (2024 Q3)
Avg. % of fund
0.93%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 305,046 -62,873 -17.1% 1.96% $3.8M $12.36
2025 Q3 REDUCED 367,919 -8,084 -2.1% 1.74% $3.2M $8.82
2025 Q2 ADDED 376,003 +756 +0.2% 1.31% $2.4M $6.38
2025 Q1 REDUCED 375,247 -1,445 -0.4% 1.06% $1.8M $4.86
2024 Q4 REDUCED 376,692 -79,516 -17.4% 1.98% $3.6M $9.56
2024 Q3 REDUCED 456,208 -9,943 -2.1% 2.07% $3.8M $8.35
2024 Q2 REDUCED 466,151 -3,936 -0.8% 1.90% $3.2M $6.82
2024 Q1 ADDED 470,087 +162,195 +52.7% 0.70% $1.2M $2.53
2023 Q4 ADDED 307,892 +155,193 +101.6% 0.45% $739K $2.40
2023 Q3 ADDED 152,699 +101,796 +200.0% 0.34% $519K $3.40
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    EBS price (monthly, adj. close)
← Back to Values First Advisors, Inc. Holdings